EDAP TMS SA -ADR (EDAP)
US2683111072 - ADR
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
Final results demonstrate a significantly higher salvage treatment free survival rate (STFS) at 30 months of 89.6% in the...
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
Company to host conference call and webcast on Thursday, May 16th at 8:30am EDT LYON, France, May 2, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”),...
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
LYON, France, April 23, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that final results from the HIFI...
EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q4 2023
EDAP stock results show that Edap TMS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Edap TMS (NASDAQ:EDAP) just reported results for the fourth quarter of 2023.Eda...
EDAP Crosses Below Key Moving Average Level
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
Company to host conference call and webcast on Wednesday, March 27th at 8:30am EDT LYON, France, March 13, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the...
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
LYON, France, March 6, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan...
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
Focal One HIFU has potential to address large market impacting thousands of women each year LYON, France, March 4, 2024 - EDAP TMS SA (Nasdaq: EDAP), the...
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
Record full-year 2023 preliminary unaudited revenue of EUR 60.4 million ($65.4 million USD), an increase of 9.6% over full-year 2022, driven by 31.7% HIFU...
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
60 Patients Completed Enrollment in Under 9 Months Study Results Expected in the Second Half of 2024 LYON, France, February 1, 2024 - EDAP TMS SA...
EDAP announces preliminary Q4 record Focal One system sales and placements (NASDAQ:EDAP)
EDAP TMS reported robust demand for its Focal One robotic HIFU technology and record sales of ExactVu Micro-Ultrasound systems in Q4.
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
Company reports preliminary placement results of twelve Focal One Systems, inclusive of ten capital sales LYON, France, January 8, 2024 - EDAP TMS SA...
EDAP TMS appoints CFO, chief accounting officer (NASDAQ:EDAP)
EDAP TMS announces the appointment of Ken Mobeck as CFO and Francois Dietsch as chief accounting officer, effective Jan. 1.
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
LYON, France, January 2, 2024 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that the...
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
LYON, France, December 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today...
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
LYON, France, November 30, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that is has received the Industry Category Award from the French National Institute for Intellectual Property (INPI) based on the Company’s innovative therapeutic ultrasound technology. On November 23, 2023, the jury for the 2023 edition of the INPI Trophies honored five companies at an awards ceremony in Paris, which spanned five different categories: Export, Industry, Start-up, Responsible Innovation, and Partnership Research.
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
LYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that...
EDAP Announces Third Quarter 2023 Financial Results
EDAP Announces Third Quarter 2023 Financial Results
- Strong Q3 2023 U.S. Focal One® HIFU procedure growth of +150% year-over-year - - Record nine months HIFU revenues reflecting growing demand - ...
EDAP to Present at the Jefferies London Healthcare Conference
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
Company to host conference call and webcast on Thursday, November 9th at 8:30am EDT LYON, France, October 26, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the...